Efficacy Double‐blind, randomized trials conducted to date support the notion that cortical stimulation via tDCS significantly reduces pain associated with many chronic indications, including in patients suffering from fibromyalgia, chronic headaches, and various forms of neuropathic pain. In many of these studies, these effects persisted past the conclusion of stimulation, with studies showing pain improvements lasting…

Our mission is to reverse the overwhelming effects of the drug abuse epidemic with Nuraleve Inc.’s revolutionary new drug treatment protocol. Nuraleve has developed a platform technology applying transcranial direct current stimulation (tDCS), through its SMARTSTIM™ device, to reduce symptoms and cravings associated with substance use disorder. It is effective with drugs such as marijuana,…